For: |
Zhu GN, Zuo L, Zhou Q, Zhang SM, Zhu HQ, Gui SY, Wang Y. Loss of heterozygosity on chromosome 10q22-10q23 and 22q11.2-22q12.1 and |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i13/1975.htm |
Number | Citing Articles |
1 |
Jun Lv, Pengfei Zhu, Xiaolei Zhang, Ling Zhang, Xiangmei Chen, Fengmin Lu, Zujiang Yu, Shuang Liu. PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma. Molecular Medicine Reports 2017; 16(4): 4475 doi: 10.3892/mmr.2017.7193
|
2 |
P. Saelee, S. Wongkham, V. Bhudhisawasdi, B. Sripa, S. Chariyalertsak, S. Petmitr. Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2008; 134(10): 1135 doi: 10.1007/s00432-008-0379-1
|
3 |
Qunli Wang, Qi Chen. Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 2): S405 doi: 10.4103/0973-1482.172585
|
4 |
Taiki Nagano, Akio Nakashima, Kengo Onishi, Kosuke Kawai, Yuto Awai, Mizuki Kinugasa, Tetsushi Iwasaki, Ushio Kikkawa, Shinji Kamada. Proline dehydrogenase promotes senescence through the generation of reactive oxygen species. Journal of Cell Science 2017; 130(8): 1413 doi: 10.1242/jcs.196469
|
5 |
Zhiwu Jiang, Lin Cheng, Zhiping Wu, Linfu Zhou, Haitao Wang, Qilan Hong, Qiting Wu, Youguo Long, Yunlin Huang, Gaoqi Xu, Yao Yao, Zhaoyang Tang, Zhenfeng Zhang, Lili Yang, Wei Luo, Jie Yang, Likun Gong, Pentao Liu, Xinwen Chen, Shuzhong Cui, Qi Zhang, Yinxiong Li, Peng Li. Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors. EMBO reports 2022; 23(6) doi: 10.15252/embr.202154275
|
6 |
Janis M. Taube, Constance A. Griffin, Raluca Yonescu, Laura Morsberger, Pedram Argani, Frederic B. Askin, Denise A.S. Batista. Pleuropulmonary Blastoma: Cytogenetic and Spectral Karyotype Analysis. Pediatric and Developmental Pathology 2006; 9(6): 453 doi: 10.2350/06-02-0044.1
|
7 |
Chien-An A. Hu, Edward I. Klopfer, Patricio E. Ray. Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease. FEBS Letters 2012; 586(7): 947 doi: 10.1016/j.febslet.2012.03.002
|
8 |
Zhi Song, Ren Li, Nan You, Kaishan Tao, Kefeng Dou. Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis. Molecular Biology Reports 2010; 37(8): 4091 doi: 10.1007/s11033-010-0069-3
|
9 |
Sandra Hakim, Micka C. Bertucci, Sarah E. Conduit, David L. Vuong, Christina A. Mitchell. Phosphoinositides and Disease. Current Topics in Microbiology and Immunology 2012; 362: 247 doi: 10.1007/978-94-007-5025-8_12
|
10 |
Juan Wang, Wenqin Song. Analysis of genotype polymorphism of tumor-related genes harbored in chromosome arm 1p and 8p in hepatocellular carcinoma patients by cSNP chip. Frontiers of Biology in China 2009; 4(1): 82 doi: 10.1007/s11515-008-0075-1
|
11 |
Marc Cool, François Depault, Paul Jolicoeur. Fine allelotyping of Erbb2‐induced mammary tumors in mice reveals multiple discontinuous candidate regions of tumor‐suppressor loci. Genes, Chromosomes and Cancer 2006; 45(2): 191 doi: 10.1002/gcc.20276
|
12 |
Mark A. Feitelson, Jungmin Lee. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Letters 2007; 252(2): 157 doi: 10.1016/j.canlet.2006.11.010
|
13 |
Michele Barone, Daniela Spano, Maria D’Apolito, Marta Centra, Carla Lasalandra, Mario Capasso, Alfredo Di Leo, Stefano Volinia, Diego Arcelli, Natalia Rosso, Antonio Franavilla, Claudio Tiribelli, Achille Iolascon. Gene Expression Analysis in HBV Transgenic Mouse Liver: A Model to Study Early Events Related to Hepatocarcinogenesis. Molecular Medicine 2006; 12(4-6): 115 doi: 10.2119/2006-00015.Barone
|
14 |
Jie Ding, Shenglin Huang, Shunquan Wu, Yingjun Zhao, Linhui Liang, Mingxia Yan, Chao Ge, Jian Yao, Taoyang Chen, Dafang Wan, Hongyang Wang, Jianren Gu, Ming Yao, Jinjun Li, Hong Tu, Xianghuo He. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nature Cell Biology 2010; 12(4): 390 doi: 10.1038/ncb2039
|
15 |
Sandra V. Fernandez, Irma H. Russo, Jose Russo. Estradiol and its metabolites 4‐hydroxyestradiol and 2‐hydroxyestradiol induce mutations in human breast epithelial cells. International Journal of Cancer 2006; 118(8): 1862 doi: 10.1002/ijc.21590
|
16 |
Tom Luedde. MicroRNA-151 and Its Hosting Gene FAK (Focal Adhesion Kinase) Regulate Tumor Cell Migration and Spreading of Hepatocellular Carcinoma†. Hepatology 2010; 52(3): 1164 doi: 10.1002/hep.23854
|
17 |
Ana R. Gomes, Ana M. Abrantes, Ana F. Brito, Mafalda Laranjo, João E. Casalta-Lopes, Ana C. Gonçalves, Ana B. Sarmento-Ribeiro, Maria F. Botelho, José G. Tralhão. Influence of P53 on the radiotherapy response of hepatocellular carcinoma. Clinical and Molecular Hepatology 2015; 21(3): 257 doi: 10.3350/cmh.2015.21.3.257
|
18 |
Zhenyu Zhang, Jinfeng Zhu, Yansong Huang, Weibing Li, Hongqiu Cheng. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway. Diagnostic Pathology 2018; 13(1) doi: 10.1186/s13000-018-0763-3
|